← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2000Last known activity
Nov 22, 2025
Timeline
1780s
- Jan 1, 1788
State of New York— Founded
Drugs by trial phase (9 distinct, 10 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
- Aggression
- Alzheimer Disease
- Arthritis
- Arthritis, Rheumatoid
- Autism Spectrum Disorder
- Autistic Disorder
- Child Development Disorders, Pervasive
- Developmental Disabilities
- Disease
- Down Syndrome
- Hypotension
- Hypotension, Orthostatic
- Language Disorders
- Self-Injurious Behavior
- Spinal Cord Injuries
- Syndrome
- Wounds and Injuries
Recent trials (13)
- NCT07091279CollaboratorPhase 2Nov 22, 2025
- NCT04060017CollaboratorPhase 2Dec 31, 2019
- NCT04060030CollaboratorPhase 2Dec 31, 2019
- NCT04047355CollaboratorPhase 2Sep 30, 2019
- NCT03602014CollaboratorPhase 4Jun 1, 2018
- NCT02311855CollaboratorPhase 4Aug 1, 2014
- NCT01329939CollaboratorN/AApr 1, 2011
- NCT02024867CollaboratorN/AFeb 1, 2010
- NCT00056329Reponsible party - principal investigatorPhase 3Apr 1, 2002
- NCT00056329Overall official - principal investigatorPhase 3Apr 1, 2002
- NCT00056329Lead sponsorPhase 3Apr 1, 2002
- NCT01594346Reponsible party - principal investigatorPhase 3Sep 1, 2000
- NCT01594346Lead sponsorPhase 3Sep 1, 2000
Details
- Founded
- Albany, NY, US Jan 1, 1788
- Last known activity
- Nov 22, 2025